Both neuronal and muscle type nAChR associated channels open in response to binding of the neurotransmitter acetylcholine [11], and antagonism of nAChR may be of interest for the treatment of pain, nicotine addiction or epilepsy [12,13], whereas agonistic action is desired for treating neurological disorders. Here, CHRNA4 is linked to nicotine dependence.